Cargando…

Cell‐Free Protein Synthesis for the Screening of Novel Azoreductases and Their Preferred Electron Donor

Azoreductases are potent biocatalysts for the cleavage of azo bonds. Various gene sequences coding for potential azoreductases are available in databases, but many of their gene products are still uncharacterized. To avoid the laborious heterologous expression in a host organism, we developed a scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolf, Jascha, Ngo, Anna Christina Reyes, Lütz, Stephan, Tischler, Dirk, Rosenthal, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401864/
https://www.ncbi.nlm.nih.gov/pubmed/35593146
http://dx.doi.org/10.1002/cbic.202200121
_version_ 1784773055485050880
author Rolf, Jascha
Ngo, Anna Christina Reyes
Lütz, Stephan
Tischler, Dirk
Rosenthal, Katrin
author_facet Rolf, Jascha
Ngo, Anna Christina Reyes
Lütz, Stephan
Tischler, Dirk
Rosenthal, Katrin
author_sort Rolf, Jascha
collection PubMed
description Azoreductases are potent biocatalysts for the cleavage of azo bonds. Various gene sequences coding for potential azoreductases are available in databases, but many of their gene products are still uncharacterized. To avoid the laborious heterologous expression in a host organism, we developed a screening approach involving cell‐free protein synthesis (CFPS) combined with a colorimetric activity assay, which allows the parallel screening of putative azoreductases in a short time. First, we evaluated different CFPS systems and optimized the synthesis conditions of a model azoreductase. With the findings obtained, 10 azoreductases, half of them undescribed so far, were screened for their ability to degrade the azo dye methyl red. All novel enzymes catalyzed the degradation of methyl red and can therefore be referred to as azoreductases. In addition, all enzymes degraded the more complex and bulkier azo dye Brilliant Black and four of them also showed the ability to reduce p‐benzoquinone. NADH was the preferred electron donor for the most enzymes, although the synthetic nicotinamide co‐substrate analogue 1‐benzyl‐1,4‐dihydronicotinamide (BNAH) was also accepted by all active azoreductases. This screening approach allows accelerated identification of potential biocatalysts for various applications.
format Online
Article
Text
id pubmed-9401864
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94018642022-08-26 Cell‐Free Protein Synthesis for the Screening of Novel Azoreductases and Their Preferred Electron Donor Rolf, Jascha Ngo, Anna Christina Reyes Lütz, Stephan Tischler, Dirk Rosenthal, Katrin Chembiochem Research Articles Azoreductases are potent biocatalysts for the cleavage of azo bonds. Various gene sequences coding for potential azoreductases are available in databases, but many of their gene products are still uncharacterized. To avoid the laborious heterologous expression in a host organism, we developed a screening approach involving cell‐free protein synthesis (CFPS) combined with a colorimetric activity assay, which allows the parallel screening of putative azoreductases in a short time. First, we evaluated different CFPS systems and optimized the synthesis conditions of a model azoreductase. With the findings obtained, 10 azoreductases, half of them undescribed so far, were screened for their ability to degrade the azo dye methyl red. All novel enzymes catalyzed the degradation of methyl red and can therefore be referred to as azoreductases. In addition, all enzymes degraded the more complex and bulkier azo dye Brilliant Black and four of them also showed the ability to reduce p‐benzoquinone. NADH was the preferred electron donor for the most enzymes, although the synthetic nicotinamide co‐substrate analogue 1‐benzyl‐1,4‐dihydronicotinamide (BNAH) was also accepted by all active azoreductases. This screening approach allows accelerated identification of potential biocatalysts for various applications. John Wiley and Sons Inc. 2022-06-16 2022-08-03 /pmc/articles/PMC9401864/ /pubmed/35593146 http://dx.doi.org/10.1002/cbic.202200121 Text en © 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Rolf, Jascha
Ngo, Anna Christina Reyes
Lütz, Stephan
Tischler, Dirk
Rosenthal, Katrin
Cell‐Free Protein Synthesis for the Screening of Novel Azoreductases and Their Preferred Electron Donor
title Cell‐Free Protein Synthesis for the Screening of Novel Azoreductases and Their Preferred Electron Donor
title_full Cell‐Free Protein Synthesis for the Screening of Novel Azoreductases and Their Preferred Electron Donor
title_fullStr Cell‐Free Protein Synthesis for the Screening of Novel Azoreductases and Their Preferred Electron Donor
title_full_unstemmed Cell‐Free Protein Synthesis for the Screening of Novel Azoreductases and Their Preferred Electron Donor
title_short Cell‐Free Protein Synthesis for the Screening of Novel Azoreductases and Their Preferred Electron Donor
title_sort cell‐free protein synthesis for the screening of novel azoreductases and their preferred electron donor
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401864/
https://www.ncbi.nlm.nih.gov/pubmed/35593146
http://dx.doi.org/10.1002/cbic.202200121
work_keys_str_mv AT rolfjascha cellfreeproteinsynthesisforthescreeningofnovelazoreductasesandtheirpreferredelectrondonor
AT ngoannachristinareyes cellfreeproteinsynthesisforthescreeningofnovelazoreductasesandtheirpreferredelectrondonor
AT lutzstephan cellfreeproteinsynthesisforthescreeningofnovelazoreductasesandtheirpreferredelectrondonor
AT tischlerdirk cellfreeproteinsynthesisforthescreeningofnovelazoreductasesandtheirpreferredelectrondonor
AT rosenthalkatrin cellfreeproteinsynthesisforthescreeningofnovelazoreductasesandtheirpreferredelectrondonor